Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment

Wickström, Anne; Nyström, Josefina; Svenningsson, Anders

doi:10.1177/1352458512461391

Forskningsartikel2013Vetenskapligt granskad

Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment

Wickström, Anne; Nyström, Josefina; Svenningsson, Anders

Sammanfattning

Conclusions: Our data support the notion that early inflammatory control in MS is essential to preserve a healthy state in MS that counteracts the negative consequences of the disease both at a personal and at a societal level.

Nyckelord

Multiple sclerosis; work ability; biological drugs; natalizumab

Publicerad i

Multiple Sclerosis
2013, Volym: 19, nummer: 5, sidor: 622-630 Utgivare: SAGE PUBLICATIONS LTD

SLU författare

Nyström, Josefina
- Institutionen för skogens biomaterial och teknologi, Sveriges lantbruksuniversitet

Globala målen

SDG8 Anständiga arbetsvillkor och ekonomisk tillväxt

UKÄ forskningsämne

Neurovetenskaper
Neurologi

Publikationens identifierare

DOI: https://doi.org/10.1177/1352458512461391

Permanent länk till denna sida (URI)

https://res.slu.se/id/publ/53989